Nomura Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.23M | Buy |
|
|||||
|
2025
Q2 | $4.09M | Hold |
|
|||||
|
2025
Q1 | $3.54M | Buy |
|
|||||
|
2024
Q4 | $2.59M | Hold |
|
|||||
|
2024
Q3 | $2.88M | Hold |
|
|||||
|
2024
Q2 | $2.68M | Sell |
|
|||||
|
2024
Q1 | $3.12M | Sell |
|
|||||
|
2023
Q4 | $3.42M | Buy |
|
|||||
|
2023
Q3 | $2.53M | Sell |
|
|||||
|
2023
Q2 | $2.92M | Buy |
|
|||||
|
2023
Q1 | $3.09M | Buy |
|
|||||
|
2022
Q4 | $3.16M | Buy |
|
|||||
|
2022
Q3 | $3.17M | Buy |
|
|||||
|
2022
Q2 | $3.1M | Buy |
|
|||||
|
2022
Q1 | $2.68M | Buy |
|
|||||
|
2021
Q4 | $2.71M | Buy |
|
|||||
|
2021
Q3 | $1.13M | Sell |
|
|||||
|
2021
Q2 | $3.17M | Sell |
|
|||||
|
2021
Q1 | $6.25M | Buy |
|
|||||
|
2020
Q4 | $6.62M | Buy |
|
|||||
|
2020
Q3 | $4.28M | Buy |
|